Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
PDII > SEC Filings for PDII > Form 10-Q on 7-May-2009All Recent SEC Filings

Show all filings for PDI INC | Request a Trial to NEW EDGAR Online Pro

Form 10-Q for PDI INC


7-May-2009

Quarterly Report


Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

FORWARD-LOOKING STATEMENTS

This report on Form 10-Q contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the Securities Act) and Section 21E of the Securities Exchange Act of 1934 (the Exchange Act). Statements that are not historical facts, including statements about our plans, objectives, beliefs and expectations, are forward-looking statements. Forward-looking statements include statements preceded by, followed by or that include the words "believes," "expects," "anticipates," "plans," "estimates," "intends," "projects," "should," "may," "will" or similar words and expressions. These forward-looking statements are contained throughout this Form 10-Q.

Forward-looking statements are only predictions and are not guarantees of future performance. These statements are based on current expectations and assumptions involving judgments about, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond our control. These statements also involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from those expressed or implied by any forward-looking statement. Many of these factors are beyond our ability to control or predict. Such factors include, but are not limited to, the following:

· The effects of the current worldwide economic and financial crisis;
· Changes in outsourcing trends or a reduction in promotional, marketing and sales expenditures in the pharmaceutical, biotechnology and life sciences industries;

? Early termination of a significant services contract or the loss of one or more of our significant customers or a material reduction in service revenues from such customers;

· Our ability to obtain additional funds in order to implement our business model;

? Our ability to successfully identify, complete and integrate any future acquisitions and the effects of any such acquisitions on our ongoing business;

· Our ability to meet performance goals in incentive-based arrangements with customers;

· Competition in our industry;

· Our ability to attract and retain qualified sales representatives and other key employees and management personnel;

· Product liability claims against us;

? Changes in laws and healthcare regulations applicable to our industry or our, or our customers', failure to comply with such laws and regulations;

· The sufficiency of our insurance and self-insurance reserves to cover future liabilities;

· Our ability to successfully develop and generate sufficient revenue from product commercialization opportunities;

· Our ability to increase our revenues and successfully manage the size of our operations;

· Volatility of our stock price and fluctuations in our quarterly revenues and earnings;

· Failure of, or significant interruption to, the operation of our information technology and communication systems; and

· The results of any future impairment testing for goodwill and other intangible assets.

Please see Part II - Item 1A - "Risk Factors" of this Form 10-Q and Part I -

  Add PDII to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for PDII - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.